Marshall Wace
EPIX

Marshall Wace’s ESSA Pharma EPIX Stock Holding History

Marshall Wace’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-181,217
Closed -$324K – 2757
2024
Q4 		$324K Buy
+181,217
New +$577K ﹤0.01% 2214
2022
Q4 		– Sell
-115,122
Closed -$209K – 3090
2022
Q3 		$209K Buy
115,122
+93,729
+438% +$247K ﹤0.01% 3071
2022
Q2 		$67K Buy
+21,393
New +$120K ﹤0.01% 3310
2022
Q1 		– Sell
-9,620
Closed -$137K – 3542
2021
Q4 		$137K Buy
+9,620
New +$107K ﹤0.01% 3296
2021
Q3 		– Sell
-14,479
Closed -$414K – 3141
2021
Q2 		$414K Buy
+14,479
New +$421K ﹤0.01% 2213

Other funds holding EPIX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $155M AUM 129.82% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AC
Aldebaran Capital Carmel, Indiana $131M AUM 34.7% 1-Year Est. Return